Glucagon-37 (oxyntomodulin) and glucagon-29 (pancreatic glucagon) in human bowel: analysis by HPLC and radioreceptorassay.
A method for assaying specifically the biologically active peptides Glucagon-37 (G-37/Oxyntomodulin/bioactive Enteroglucagon) and Glucagon-29 (G-29/pancreatic Glucagon) has been developed by use of high performance liquid chromatography (HPLC) of crude tissue extracts followed by radioreceptorassay in liver membranes. The peaks observed with this method in samples from human bowel have also been analysed in two other assays: stimulation of cyclic AMP accumulation in gastric glands and radioimmunoassay. Owing to the different patterns of activity of porcine G-37 and G-29 in these assays, the comparison of the data obtained allows to discriminate between the two peptides. The same behaviour in both HPLC and the three assays of the human peaks on one hand and the porcine peptides on the other strongly suggests that human intestine contains a very similar or the same molecules as that isolated from the porcine tissues. Whatever the portion of small intestine, G-37 represented ca 90% of G-37 + G-29. A decreasing concentration gradient of both G-37 and G-29 was also observed from ileum to descending colon.
D000818:Animals; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D003106:Colon / Q000032:analysis*; D004847:Epithelial Cells; D005768:Gastrointestinal Hormones / Q000032:analysis*; D005934:Glucagon / Q000032:analysis*; D004763:Glucagon-Like Peptides / Q000032:analysis*; D006801:Humans; D007082:Ileum / Q000032:analysis*; D007583:Jejunum / Q000032:analysis*; D009928:Organ Specificity; D053772:Oxyntomodulin; D011869:Radioligand Assay; D013552:Swine
D005768:Gastrointestinal Hormones; D053772:Oxyntomodulin; D004763:Glucagon-Like Peptides; D005934:Glucagon